OTCPK:RQHT.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Reliq Health Technologies

Executive Summary

Reliq Health Technologies Inc., a healthcare technology company, engages in the development of mobile software solutions for community care market. More Details


Snowflake Analysis

Mediocre balance sheet with weak fundamentals.


Similar Companies

Share Price & News

How has Reliq Health Technologies's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: RQHT.F's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

2.3%

RQHT.F

1.6%

US Healthcare Services

1.0%

US Market


1 Year Return

-42.6%

RQHT.F

53.8%

US Healthcare Services

13.6%

US Market

Return vs Industry: RQHT.F underperformed the US Healthcare Services industry which returned 53.8% over the past year.

Return vs Market: RQHT.F underperformed the US Market which returned 13.6% over the past year.


Shareholder returns

RQHT.FIndustryMarket
7 Day2.3%1.6%1.0%
30 Day-4.0%-2.7%-0.4%
90 Day-23.0%11.5%8.9%
1 Year-42.6%-42.6%54.2%53.8%16.2%13.6%
3 Year-15.0%-15.0%102.6%101.3%40.2%30.8%
5 Year-15.3%-15.3%152.5%150.3%89.6%68.2%

Price Volatility Vs. Market

How volatile is Reliq Health Technologies's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Reliq Health Technologies undervalued compared to its fair value and its price relative to the market?

22.27x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate RQHT.F's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate RQHT.F's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: RQHT.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: RQHT.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate RQHT.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: RQHT.F is overvalued based on its PB Ratio (22.3x) compared to the US Healthcare Services industry average (5.3x).


Next Steps

Future Growth

How is Reliq Health Technologies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

41.8%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Reliq Health Technologies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of RQHT.F’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Reliq Health Technologies's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Reliq Health Technologies performed over the past 5 years?

-36.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: RQHT.F is currently unprofitable.

Growing Profit Margin: RQHT.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: RQHT.F is unprofitable, and losses have increased over the past 5 years at a rate of 36.7% per year.

Accelerating Growth: Unable to compare RQHT.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: RQHT.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (-4.8%).


Return on Equity

High ROE: RQHT.F has a negative Return on Equity (-977.16%), as it is currently unprofitable.


Next Steps

Financial Health

How is Reliq Health Technologies's financial position?


Financial Position Analysis

Short Term Liabilities: RQHT.F's short term assets (CA$1.5M) do not cover its short term liabilities (CA$1.7M).

Long Term Liabilities: RQHT.F's short term assets (CA$1.5M) exceed its long term liabilities (CA$92.7K).


Debt to Equity History and Analysis

Debt Level: RQHT.F is debt free.

Reducing Debt: RQHT.F had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: RQHT.F has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: RQHT.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 41% each year


Next Steps

Dividend

What is Reliq Health Technologies's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate RQHT.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate RQHT.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if RQHT.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RQHT.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of RQHT.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.0yrs

Average management tenure


CEO

Lisa Crossley

4.67yrs

Tenure

CA$226,600

Compensation

Dr. Lisa Crossley PhD, P.Eng. has been Chief Executive Officer of Reliq Health Technologies Inc. since January 18, 2016. Dr. Crossley was Chief Executive Officer of VitalHub Corp. Dr. Crossley served as Ch ...


CEO Compensation Analysis

Compensation vs Market: Lisa's total compensation ($USD171.71K) is below average for companies of similar size in the US market ($USD595.72K).

Compensation vs Earnings: Lisa's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Lisa Crossley
CEO & Director4.67yrsCA$226.60k1.33%
CA$ 329.7k
Matthew Lee
Chief Financial Officer0.50yrno datano data
Rob Prouse
Chief Technology Officer1.5yrsno data0.086%
CA$ 21.3k
Bassma Ghali
Chief Innovation Officerno datano datano data
Lucas Smithen
Chief Product Officerno datano datano data
Joyce Johnson
Chief Medical Officer & Medical Advisory Board Memberno datano datano data

1.0yrs

Average Tenure

Experienced Management: RQHT.F's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Lisa Crossley
CEO & Director4.67yrsCA$226.60k1.33%
CA$ 329.7k
Joyce Johnson
Chief Medical Officer & Medical Advisory Board Memberno datano datano data
Eugene Beukman
Director5.17yrsCA$63.50k0.15%
CA$ 38.4k
Brian Storseth
Independent Director4.17yrsCA$120.00k0.096%
CA$ 23.9k
Scott Howell
Medical Advisory Board Member1.58yrsno datano data
Bruce Kinosian
Medical Advisory Board Member1.58yrsno datano data
Dionne Hinds
Medical Advisory Board Member0.33yrno datano data
Camellus Ezeugwu
Medical Advisory Board Memberno datano datano data
Leo Godreault
Medical Advisory Board Memberno datano datano data
Susan Goebeler
Medical Advisory Board Memberno datano datano data

2.9yrs

Average Tenure

Experienced Board: RQHT.F's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: RQHT.F insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.4%.


Top Shareholders

Company Information

Reliq Health Technologies Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Reliq Health Technologies Inc.
  • Ticker: RQHT.F
  • Exchange: OTCPK
  • Founded: 2005
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Market Cap: CA$32.670m
  • Listing Market Cap: CA$24.757m
  • Shares outstanding: 145.20m
  • Website: https://www.reliqhealth.com

Number of Employees


Location

  • Reliq Health Technologies Inc.
  • 175 Longwood Road South
  • Suite 406A
  • Hamilton
  • Ontario
  • L8P 0A1
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RHTTSXV (TSX Venture Exchange)YesCommon SharesCACADFeb 2006
MHN2DB (Deutsche Boerse AG)YesCommon SharesDEEURFeb 2006
RQHT.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDFeb 2006

Biography

Reliq Health Technologies Inc., a healthcare technology company, engages in the development of mobile software solutions for community care market. It offers iUGO Health technology platform, a hardware and ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/19 06:07
End of Day Share Price2020/09/18 00:00
Earnings2020/03/31
Annual Earnings2019/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.